CD274 and neoplasm: Despite the high PD‐L1 expression of PD‐L1, tumor‐infiltrating lymphocytes (TILs) and tumor mutational burden (TMB) in BTC, the response to immunotherapy has been reported to be unsatisfactory.11, 25, 26